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AbsTrACT
Introduction Defining and accurately measuring abortion-
related morbidity is important for understanding the 
spectrum of risk associated with unsafe abortion and for 
assessing the impact of changes in abortion-related policy 
and practices. This systematic review aims to estimate the 
magnitude and severity of complications associated with 
abortion in areas where access to abortion is limited, with a 
particular focus on potentially life-threatening complications.
Methods A previous systematic review covering the 
literature up to 2010 was updated with studies identified 
through a systematic search of Medline, Embase, Popline and 
two WHO regional databases until July 2016. Studies from 
settings where access to abortion is limited were included if 
they quantified the percentage of abortion-related hospital 
admissions that had any of the following complications: 
mortality, a near-miss event, haemorrhage, sepsis, injury 
and anaemia. We calculated summary measures of the 
percentage of abortion-related hospital admissions with each 
complication by conducting meta-analysis and explored 
whether these have changed over time.
results Based on data collected between 1988 and 2014 
from 70 studies from 28 countries, we estimate that at least 
9% of abortion-related hospital admissions have a near-miss 
event and approximately 1.5% ends in a death. Haemorrhage 
was the most common complication reported; the pooled 
percentage of abortion-related hospital admissions with 
severe haemorrhage was 23%, with around 9% having near-
miss haemorrhage reported. There was strong evidence for 
between-study heterogeneity across most outcomes.
Conclusions In spite of the challenges on how near 
miss morbidity has been defined and measured in the 
included studies, our results suggest that a substantial 
percentage of abortion-related hospital admissions have 
potentially life-threatening complications. Estimates that 
are more reliable will only be obtained with increased 
use of standard definitions such as the WHO near-miss 
criteria and/or better reporting of clinical criteria applied 
in studies.
InTroduCTIon
Unsafe abortion remains a considerable public 
health problem, with the most recent global 
incidence estimates suggesting 25.1 million 
women had undergone an ‘unsafe’ abor-
tion annually between 2010 and 2014.1 The 
WHO considers an abortion to be safe if it is 
Key questions
What is already known?
 ► It was recently estimated that 25 million women 
sought an unsafe abortion in 2014. By defining and 
accurately measuring abortion-related morbidity, we 
can start to tease out the spectrum of risk associat-
ed with unsafe abortion.
 ► In a previous systematic review, including literature 
published until July 2010, Alder and colleagues 
estimated that the median prevalence of severe 
complications ranged from 1.6% for renal failure to 
7.2% for severe trauma, with a median case fatality 
of 3.3% among women who had postabortion com-
plications in areas with limited access to abortion.
What are the new findings?
 ► This systematic review identified 35 studies report-
ing on the complications among abortion-related 
hospital admissions published since the end date 
of the search strategy used by Adler et al, giving a 
total of 70 studies when added to those identified by 
the previous review. We identify that a substantial 
percentage of abortion-related hospital admissions 
have potentially life-threatening complications, with 
no improvement noted in the percentage of abor-
tion-related complications with these extremely se-
vere outcomes over time.
What do the new findings imply?
 ► The finding that a high percentage of women seek-
ing postabortion care experience life-threatening 
complications underlines the importance of ensur-
ing access to safe abortion to prevent complications 
and of providing high-quality care for complications 
when they do occur.
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provided with a safe, WHO recommended method and 
by a trained person.1 What constitutes a safe method or 
a trained person has evolved over time with changes in 
evidence-based guidelines, including with respect to the 
role of non-physician healthcare providers.2 A particu-
larly major shift in recent years has been increased access 
to and use of medical abortion, with potential for access 
for self-use especially in areas where abortion services are 
extremely restricted or illegal.3 4 
Complexities in the legal and healthcare environment 
mean that abortions cannot simply be categorised as 
either safe or unsafe. The WHO now uses three categories, 
safe, less safe and least safe abortions,1 which represent 
a gradient of risk depending on factors including abor-
tion method, provider and gestational age. By defining 
and accurately measuring abortion-related morbidity, we 
can start to tease out the spectrum of risk associated with 
unsafe abortion. At the extreme end, the adverse health 
outcomes of an unsafe abortion can include mortality 
and near-miss morbidity (complications which would 
have most likely resulted in death had the woman not 
made it to hospital).5
A systematic review published in 2012 attempted to 
quantify the severity of abortion-related complications.6 
Based on data from 43 studies, Adler and colleagues 
estimated that the median prevalence of severe compli-
cations ranged from 1.6% for renal failure to 7.2% for 
severe trauma, with a median case fatality of 3.3% among 
women who had postabortion complications. The 
authors, however, also highlighted several methodolog-
ical issues hindering their ability to combine results from 
the studies meaningfully, including substantial between-
study heterogeneity.
This paper provides a timely update of the review by 
Adler and colleagues, given the change in the landscape 
of abortion services, notably the increased availability of 
medical abortion in many settings and greater access to 
safer surgical abortion care and the increasing aware-
ness that understanding the safety of abortion requires 
better data on morbidity.7 The objective of this review is 
to update the systematic review by Adler et al, identifying 
studies quantifying the complications associated with 
abortions in regions where access to abortion is limited, 
and to provide estimates of the magnitude and severity 
of complications associated with abortion with a partic-
ular focus on potentially life-threatening complications, 
including near-miss morbidity and mortality. Unlike the 
previous review, we also examine potential sources of 
between-study heterogeneity in estimates of abortion-re-
lated severe morbidity and mortality using meta-regres-
sion and explore how complications of abortion have 
changed over time.
MeTHods
search strategy
A review protocol outlining the methods for our system-
atic review was developed (available on request from 
corresponding author). We included most studies 
identified in the review by Adler et al,6 covering litera-
ture published up to 1 July 2010. Eight studies from the 
Adler et al review were not included in this review due to 
stricter inclusion criteria (further details below). To iden-
tify studies published since July 2010, the search strategy 
developed by Adler et al was used to search Medline, 
Embase, Popline and two of the WHO regional databases 
(Latin American and Caribbean Health Sciences Litera-
ture (LILACS) and African Index Medicus (AIM)) from 
January 2010 to July 2016. For Medline and Embase, the 
search identified articles where their abstract, title or 
keywords contained an abortion term and a term related 
to a comprehensive list of morbidities or mortality. For 
the simpler databases—Popline and LILACS—a simpli-
fied search was conducted, including all studies referring 
to abortion and reference to at least one of a simple list 
of complications. For AIM, all articles referring to abor-
tion were included. The search strategy is available in the 
online Supplementary appendix 1. Additional publica-
tions were identified by manually searching the reference 
lists of included articles.
study selection
Titles and abstracts identified by the search strategy were 
exported into EndNote (2010–2013) or EPPI-reviewer 
(2014–2016) and two authors out of three (CC, FY and 
OO) screened each abstract. Where there was disagree-
ment, the two authors discussed the abstract to decide 
whether it should be included for full-text review. One 
author reviewed each of the full texts identified as poten-
tially relevant at the abstract screening stage for inclusion 
in the review (CC and FY).
Studies were included if they reported a breakdown 
of the complications of hospital-related abortion admis-
sions in a sample of at least 30 women, in a setting where 
there is limited access to abortion services. Settings with 
‘limited access to abortion’ were defined in line with 
Adler et al where countries were classified ‘based on the 
WHO estimates of the numbers of complications dues 
to abortions’.6 Studies from the following WHO regions 
were excluded, as the burden of unsafe abortion is ‘negli-
gible’: AMRO A, EURO A and WPRO A.8 Trials assessing 
the effectiveness of different methods of abortion were 
also excluded as it was assumed that the abortions would 
be safe under trial conditions. Due to the poor validity 
of self-report of complications, studies were excluded if 
they relied on self-report of complications.9 10 Studies 
were excluded if they did not provide a measure of the 
number of abortion-related hospital admissions or only 
looked at a subgroup of abortion-related hospital admis-
sions (eg, septic abortions only or only women admitted 
to an intensive care unit). This final exclusion criteria was 
not applied in the study by Adler et al.6
data extraction
Data from all relevant studies were extracted by a single 
author (CC or FY) into an extraction form developed in 
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Excel, with extraction double-checked by a second author 
(CC or FY). Articles included in the review by Adler et al6 
were re-extracted to ensure that consistent decisions were 
made with respect to the classification of the complica-
tions of unsafe abortion. Basic descriptive information 
for each study was extracted on the study design and the 
study population. For the study population, we catego-
rised the types of abortion included in the study sample 
as follows: ‘all’ abortions, spontaneous and induced 
abortions or only induced abortions. Where results were 
presented stratified by the type of abortion, we added 
together estimates to give the total number of compli-
cations across induced and spontaneous abortions, due 
to the challenges in identifying induced abortions only.11 
The gestational age of the study sample was noted where 
reported.
Data were extracted for each study on the number of 
abortion-related hospital admissions and the definition 
and number of abortion-related hospital admissions with 
the following outcomes: severe complications (as defined 
by authors); near-miss events defined as ‘a woman who 
nearly died but survived a complication that occurred 
during pregnancy, childbirth or within 42 days of termi-
nation of pregnancy’5 12 and; mortality. Data were also 
extracted on the number of women with abortion who 
had the following complications: haemorrhage, infec-
tion, injury (injury to the cervix or vaginal area or uterine 
perforation) and anaemia. For these complications, we 
extracted information on each complication according 
to whether the definition in the study could be classi-
fied as ‘near miss’, ‘severe’ or ‘not severe/unspecified’. 
Further details of this classification are provided in the 
online Supplementary table 1 (online Supplementary 
appendix 2).
For studies that did not report the total number of 
abortion-related hospital admissions with near miss, but 
did provide some individual criterion of complications or 
organ dysfunction that could be categorised as near miss, 
we calculated a minimum estimate for the number abor-
tion-related hospital admissions with a near-miss event. 
Two different methods were used depending on the type 
of data available in the study:
1. For studies where each abortion-related hospital ad-
mission was assigned to only one complication, catego-
ries of complications which could be considered near 
miss were added together to give an estimate of the 
number of near miss cases.
2. For studies where each abortion-related hospital ad-
mission could be assigned to multiple conditions, we 
selected only one criterion that could be considered 
near miss (in most cases shock).
Where data were presented in the study stratified by 
the method of abortion, we extracted an estimate of the 
complications associated with abortions induced using 
misoprostol (as self-reported or suspected by the health-
care provider). Similarly, we extracted estimates stratified 
by gestational age where available.
Assessment of the risk of bias
The risk of bias was determined using the component 
approach outlined by The Cochrane Collaboration for 
a number of predefined quality criteria. All studies were 
assessed as at high or low risk of bias on the following 
criteria:
1. Representativeness of the study population—high risk 
of bias if studies were not representative of a clearly 
defined geographical region (eg, a district).
2. Completeness of case ascertainment—high risk of bias 
if records were only examined from one or two hospi-
tal departments (eg, Obstetrics and Gynaecology de-
partment), rather than all departments of the facility 
which may admit women with abortion complications.
3. Quality of complication diagnosis—high risk of bias if 
this was done retrospectively, rather than prospectively.
If a study did not contain sufficient information to clas-
sify it as at either high or low risk, it was classified as at 
unclear risk of bias.
data synthesis and analysis
For each study, we calculated the percentage of abor-
tion-related hospital admissions attributable to: near 
miss (overall, due to haemorrhage, sepsis, injury and 
anaemia); severe complications (overall, haemorrhage, 
sepsis and anaemia); not severe/unspecified compli-
cations (haemorrhage, sepsis, injury and anaemia) 
and death. Some studies did not report on whether 
any deaths were observed among the hospital-related 
abortion admissions, most likely because there were no 
deaths. We therefore assumed that mortality was 0% in 
these studies for our overall estimate of case fatality, but 
conducted sensitivity analyses removing these studies to 
see how this influenced our estimate. Excluding studies 
with no deaths reported provides a ceiling estimate of 
case fatality.
For near miss and mortality, pooled estimates of the 
percentage of abortion-related hospital admissions that 
had each outcome were calculated using the DerSimo-
nian-Laird random effects method in R V.3.4.1.13 These 
pooled estimates were stratified by median year in which 
the study was conducted: an early period (1990–1995) 
when misoprostol was unlikely to be widely available; a 
mid-period (1996–2008) when misoprostol was being 
rolled out in many settings and a late period (2009–
2013) when misoprostol was likely to be available in 
many settings. The percentage of the variation between 
study estimates which was due to between-study differ-
ences, rather than chance, was calculated in the form of 
the I2 statistic.14 Using median year of study as a study-
level measure of the time period in which the study 
was conducted will be less reliable for studies spanning 
long time periods. We therefore conducted a sensitivity 
analysis of the pooled estimates by median year of study, 
removing any studies longer than 5 years.
In STATA V.15.0, meta-regression was subsequently 
used to explore study-level factors which may be associ-
ated with between-study heterogeneity (region, definition 
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of abortion, median year of data collection and whether 
the study was conducted in a non-population representa-
tive sample of facilities or in facilities that were represen-
tative at the district or national level) for both case fatality 
and near miss. For estimates of the percentage of abor-
tion-related hospital admissions that were near miss, we 
also explored the method used to calculate the number 
of near miss abortion-related hospitals admissions as a 
source of between-study heterogeneity. This was divided 
into three groups as follows: (1) authors provided esti-
mate of near miss; (2) we added categories of complica-
tions which could be considered near miss and (3) we 
used the single largest reported near miss event for a 
minimum estimate.
To explore whether the composition of complications 
among abortion-related hospital admissions has changed 
over time, pooled estimates of the percentage of abor-
tion-related hospital admissions attributable to each 
cause (haemorrhage, sepsis, injury and anaemia) was 
calculated using the DerSimonian-Laird random effects 
method, stratified by severity of the complication and by 
the median year of study (as described above).
resulTs
search strategy results
As shown in figure 1, 8627 titles and abstracts were iden-
tified for review from the search strategy from 2010 to 
July 2016. Of these titles and abstracts, 379 were identi-
fied as potentially useful and full texts were sought. Only 
three full texts could not be located. Thirty-three of the 
reviewed full texts met the inclusion criteria, with most 
studies being excluded for not providing information 
on the complications of abortion (n=107) or for only 
including safe abortions (n=80). Two additional articles 
were identified by manually searching the reference list 
of included articles, resulting in 35 relevant studies for 
July 2010–July 2016. Combining these recent studies with 
those identified in the earlier review gave 70 studies. Four 
studies provided estimates of complications among abor-
tion-related hospital admissions by misoprostol versus 
other methods,15–18 and 10 studies stratified estimates by 
gestational age.15 16 19–26
study characteristics
The online Supplementary table 2 describes the 70 
studies, of which 39 were from Africa, 22 from Asia and 
nine from Latin America. The time during which data 
were collected varied considerably between studies. The 
earliest data come from 1988, with the median year of 
data collection in 1990–1995 for 12 studies, in 1996–2008 
for 33 studies and from 2009 to 2013 for 21 studies. Four 
studies did not provide information on when data were 
collected and were grouped separately for all analyses 
by time period. Three studies had data collected which 
spanned more than 5 years27–29; although for one of these 
studies, it was possible to extract data for a shorter period 
of time.29
The overall risk of bias of the studies is shown in the 
online Supplementary figure 1. Only 10 of the studies 
described sampling facilities that were representative 
at the district or national level (14.3%). Most studies 
included women from only a single facility (n=43, 61.4%), 
with nine studies recruiting from between two and five 
facilities (12.9%) and seven studies recruiting from 
more than five facilities (10.0%). One study provided no 
details on how women were identified. Most studies did 
Figure 1 Search process for selection of papers.
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not provide sufficient detail to allow us to assess whether 
all cases of abortion in a facility were likely to be included 
(n=38, 54.3%), while four studies were classified at low 
risk of bias for missing cases of abortion (5.7%), as they 
described collecting data for all or most hospital depart-
ments. The remaining 28 studies only look at cases within 
certain departments of the facility (40.0%), largely the 
obstetrics and gynaecology department. Finally, 26 studies 
were conducted retrospectively (37.1%), 43 prospectively 
(61.4%) and one did not provide information to assess 
this (1.4%).
Thirteen studies reported both spontaneous and 
induced abortion (18.6%); 41 reported only induced 
abortion (58.6%) and 16 did not specify abortion type 
and/or stated all abortions were included (22.9%). 
Further details on the definition of ‘abortion-related 
hospital admissions’ for each study can be found in the 
online Supplementary table 3.
Mortality among abortion-related hospital admissions
The estimates of case fatality among abortion-related 
hospital admissions ranged from 0% to 22.0% across 
68 studies either explicitly reporting case fatality or not 
mentioning any deaths in the study population in which 
case we assumed case fatality to be 0% (online Supple-
mentary table 3). As shown in figure 2, the overall 
pooled case fatality was 1.5% (95% CI: 1.1 to 2.0). There 
was no evidence for a difference between case fatality 
among studies conducted in the early period (pooled 
case fatality=2.6%, 95% CI 0.9 to 5.1) compared with 
studies from the most recent time period (pooled case 
fatality=3.1%, 95% CI 1.5 to 5.1). There was strong 
evidence for between-study heterogeneity across all 
pooled estimates of case fatality. As shown in the online 
Supplementary table 4, there was little influence of the 
studies that spanned more than 5 years of data collection. 
Exclusion of studies that did not mention whether there 
were any deaths in the study population, increased our 
overall estimate of case fatality from 1.5% to 2.4% (95% 
CI 1.8 to 3.0) and led to increased estimates across each 
time period (online Supplementary table 4 and online 
Supplementary figure 2).
In univariate meta-regression of the 68 studies of 
case fatality, there was evidence that type of abortion 
(p=0.005), region (p=0.03) and inclusiveness of the 
sampling strategy (p=0.03) influenced the between 
study variation in case fatality (table 1). In the multi-
variable meta-regression model, only type of abortion 
(induced or spontaneous) remained independently 
associated with case fatality (p=0.005). Studies of only 
induced abortions had, on average, higher case fatality 
than studies that included women with all types of abor-
tion or did not explicitly state the type of abortions 
included.
Only one study reported case fatality by abortion 
method, with only two deaths reported among women 
where the method of abortion was ‘not known’.16 Six 
studies provided estimates of case fatality by gestational 
age,19 20 22–25 and in all studies the case fatality was higher 
at later gestation (online Supplementary table 3).
near miss among abortion-related hospital admissions
As shown in the online Supplementary table 3, 48 
studies provided estimates of the percentage of abor-
tions that were near miss, although only three of these 
used near miss criteria to do so (two used WHO criteria, 
while the third defined the outcome as any of acute 
renal failure, severe haemorrhage requiring blood 
transfusion, hypovolemic shock, sepsis with or without 
shock or disseminated intravascular coagulation). For 
14 studies, we calculated the total number of near-miss 
events by summing all near miss complications, as only 
a single complication meeting the near miss criteria was 
presented for each abortion-related hospital admission. 
The remaining 32 studies reported multiple complica-
tions per abortion so we only included a single near miss 
complication that accounted for the largest number of 
abortion-related hospital admissions. The percentage of 
abortion-related hospital admissions classified as having 
a near miss event ranged from 0.5% to 56.5% across the 
studies. Estimates from only the three studies that used 
near miss criteria ranged from 14.7% to 56.5%. The 
pooled percentage of abortion-related hospital admis-
sions with near miss events, overall and stratified by time, 
is shown in figure 3. Overall, 8.9% of abortion-related 
hospital admissions were estimated to have near miss 
morbidity (95% CI: 6.7 to 11.3). The estimates from 
studies in the early period had a pooled percentage of 
5.7% (95% CI: 2.2 to 10.7) compared with 18.3% among 
studies in the late period (95% CI: 9.6 to 29.1). There 
was, however, strong evidence of between study heter-
ogeneity in all time periods (I2 ≥95%, P<0.001). The 
sensitivity analysis, removing the estimates that spanned 
more than 5 years, did not change the results appreciably 
(online supplementary table 5).
In the univariate meta-regression, there was evidence 
that time period (P=0.007) and method of calculating 
near miss (p=0.003) influenced the between-study vari-
ation in the percentage of abortion-related hospital 
admissions which with near miss morbidity (table 1). 
In the multivariate meta-regression model, both time 
period (P=0.08) and method of calculating near miss 
(P=0.02), remained independently associated with the 
percentage of near miss events among abortion-related 
hospital admissions. Studies where the median year of 
data collection was more recent (2009–2013) had, on 
average, a higher percentage of abortion-related hospital 
admissions with near miss, compared with studies in the 
early time period. Studies where only a single near miss 
criterion was used to estimate the percentage of abor-
tion-related hospital admissions that were near miss 
had the lowest percentage attributable to near miss, 
whereas studies using near miss criteria had the highest 
percentage. After adjusting for time period and method 
of calculating near miss, there was no evidence that type 
of abortion (P=0.24), region (P=0.23) or population 
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Figure 2 Forest plot of the percentage of women with abortion-related hospital admissions who died.
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(P=0.11) were associated with the percentage of abor-
tion-related hospital admissions with near miss.
It was possible to estimate the percentage of abor-
tion-related hospital admissions with a near miss event 
separately for abortions induced with misoprostol for 
three studies, and we do see a lower risk of near miss 
events in this group. However, differences in the methods 
used by women who did not take misoprostol between 
Table 1 Meta-regression for case fatality and near-miss events among abortion-related hospital admissions
Outcome and study 
group
Number 
of studies
% with 
outcome 
(95% CI) Crude OR (95% CI) P values Adjusted OR (95% CI)*
P values*Case fatality Adjusted R2=12.5%
Median year of study
  1990–1995 10 2.6 (0.9–5.1) 1 1
  1996–2008 33 0.9 (0.6–1.4) 0.41 (0.06 to 2.68) 0.76 (0.12 to 4.61)
  2009–2013 21 3.1 (1.5–5.1) 1.17 (0.16 to 8.56) 0.31 1.63 (0.25 to 10.79) 0.56
Type of abortion
  All/unspecified abortion 16 0.2 (0–0.5) 1 1
  Spontaneous+induced 11 0.5 (0.2–1.0) 1.73 (0.25 to 11.88) 1.73 (0.25 to 11.88)
  Induced only 41 4.1 (2.5–6.1) 9.68 (2.27 to 41.27) 0.005 9.68 (2.27 to 41.27) 0.005
Region
  Africa 39 1.8 (1.2–2.6) 1 1
  Asia 22 2.1 (1.3–3.1) 1.62 (0.42 to 6.21) 1.05 (0.27 to 4.05)
  Latin America 7 0 (0–0.5) 0.08 (0.01 to 0.66) 0.03 0.16 (0.02 to 1.52) 0.26
Sampling strategy
  Facility 54 2.7 (1.9–3.6) 1 1
  Population 10 0.2 (0.1–0.4) 0.14 (0.02 to 0.81) 0.03 0.22 (0.03 to 1.83) 0.16
Near miss Adjusted R2=23.9%
Median year of study
  1990–1995 6 5.7 (2.2–10.7) 1 1
  1996–2008 27 6.6 (4.3–9.3) 1.55 (0.56 to 4.31) 1.16 (0.36 to 3.71)
  2009–2013 14 18.3 (9.6–29.1) 5.09 (1.63 to 15.89) 0.007 2.76 (0.79 to 9.65) 0.08
Type of abortion
  All/unspecified abortion 10 9.4 (3.9–16.8) 1 1
  Spontaneous+induced 8 4.0 (2.3–6.1) 0.61 (0.17 to 2.22) 0.86 (0.25 to 2.94)
  Induced only 30 10.7 (7.5–14.3) 1.64 (0.61 to 4.42) 0.17 1.73 (0.67 to 4.49) 0.24
Region
  Africa 25 7.9 (5.4–10.8) 1 1
  Asia 19 12.6 (6.9–19.5) 1.53 (0.67 to 3.47) 1.01 (0.47 to 2.14)
  Latin America 4 3.2 (0.4–8.5) 0.32 (0.08 to 1.39) 0.11 0.18 (0.03 to 1.32) 0.23
Sampling strategy
  Facility 40 10.7 (7.5–14.5) 1 1
  Population 8 3.2 (2.0–4.5) 0.35 (0.12 to 0.97) 0.05 0.47 (0.19 to 1.19) 0.11
Method of calculating near miss
  WHO or other near-miss 
criteria
3 26.6 (9.1–49.0) 1 1
  Addition of near miss 
due to complications
11 17.2 (6.6–31.3) 0.49 (0.10 to 2.48) 0.65 (0.14 to 3.14)
  Single near-miss 
criterion
34 5.7 (4.0–7.5) 0.14 (0.03 to 0.64) 0.003 0.23 (0.05 to 0.99) 0.02
*Case fatality model adjusted for type of abortion. Near-miss events model adjusted for method of calculating near-miss cases and for 
median year of study.
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Figure 3 Forest plot of the percentage of abortion-related hospital admissions with a near miss complication.
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the studies makes it difficult to compare across the 
studies.16–18 Of the four studies where estimates of the 
percentage of abortion-related hospital admissions which 
had near miss complications could be stratified by gesta-
tional age,16 19 23 26 three studies reported the percentage 
to be higher among abortions at a later gestational 
age16 19 23 (online Supplementary table 2).
Cause-specific complications among abortion-related 
hospital admissions
Haemorrhage
The online Supplementary table 6 provides study-spe-
cific definitions and estimates for studies that report the 
percentage of abortion-related hospital admissions which 
had complications classified as due to haemorrhage. 
Overall, 26 studies provided an estimate of unspecified 
or not severe haemorrhage, with 10 studies providing 
estimates for severe haemorrhage and 16 for near miss 
haemorrhage. The pooled percentage of abortion-re-
lated hospital admissions with complications of non-se-
vere or unspecified haemorrhage was 56.6% (95% CI 40.5 
to 72.1, I2=100%). For severe haemorrhage, the pooled 
percentage was 23.0% (95% CI 17.3 to 29.3, I2=97%). 
The pooled percentage of abortion-related hospital 
admissions with near miss haemorrhage was 8.7% (95% 
CI 4.5 to 16.0.4, I2=99%).
As shown in figure 4A, the pooled percentage of abor-
tion-related hospital admissions with complications 
related to near miss due to haemorrhage is substantially 
lower across studies with a median year of data collec-
tion between 1990 and 1995 (pooled percentage=3.1%, 
95% CI 0.2 to 8.7) compared with those from 2009 to 
2013 (pooled percentage=26.9%, 95% CI 17.8 to 37.0). 
A similar trend is observed for severe haemorrhage and 
unspecified/non-severe haemorrhage but estimates 
between the different time periods are consistent within 
CIs.
Sepsis
Forty-three studies reported the percentage of abor-
tion-related hospital admissions with non-severe or 
unspecified infection; 50 reported on severe infection 
and 19 reported near miss due to infections (study 
specific definitions and estimates given in the online 
Supplementary table 7). The pooled percentage of 
abortion-related hospital admissions with complications 
Figure 4 Pooled percentage of abortion-related hospital admissions with (A) haemorrhage, (B) sepsis, (C) injury and (D) 
anaemia. All estimates are stratified by severity of the complication and time period.
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attributable to unspecified or not severe infection was 
18.3% (95% CI 10.4 to 27.7, I2=100%). For severe infec-
tion, the pooled percentage was slightly lower (17.0%, 
95% CI 14.0 to 20.2, I2=99%) and for near miss infection, 
the pooled percentage was much lower (2.8%, 95% CI 
1.3 to 4.6, I2=93%).
Studies with a median data collection year in the early 
period had lower pooled percentage of abortion-related 
hospital admissions with near miss infection than studies 
with a median year of data collection in most recent time 
period (0.4% vs 9.2%) (figure 4B); however, the esti-
mate for the early period is based on only two studies, 
and the CI for the pooled percentage in the most recent 
time period is very wide. No difference in the pooled 
percentage by year of data collection was observed for 
severe infection or for unspecified/non-severe infection.
Injury
As shown in the online Supplementary table 8, 51 studies 
reported on the percentage of abortion complications 
due to non-severe or unspecified injuries and 21 studies 
reported on near miss due to injuries. The pooled 
percentage of abortion-related hospital admissions with 
non-severe or unspecified injury was 5.6% (95% CI 4.2 
to 7.1, I2=98%). There was no evidence that pooled 
percentage changed by median year of study (figure 4C).
For near miss due to injuries, we estimated a pooled 
percentage of 4.1% (95% CI 2.2 to 6.6, I2=95%). As illus-
trated in figure 4C, the pooled percentage for studies 
with a median year of data collection in the most recent 
period was higher than for studies with earlier median 
data collection dates, but the CIs were very wide and 
consistent with the pooled estimates from the other time 
periods.
Anaemia
Only five studies reported on the percentage of abor-
tion-related hospital admissions with severe anaemia, and 
all these studies had a median year of data collection in 
the most recent time period (online Supplementary table 
9), with the exception of one study which did not provide 
study dates. We estimated a pooled percentage of 12.4% 
(95% CI 3.9 to 24.5, I2=91%) across the five studies.
Eleven studies provided estimates for non-severe or 
unspecified anaemia (online Supplementary table 9), 
with study estimates ranging from 4.3% up to 77.0% of 
abortion-related hospital admissions. Overall, there was 
a pooled percentage of 38.6% (95% CI 20.9 to 58.0, 
I2=99%), with no evidence that this has changed over 
time (figure 4D).
dIsCussIon
This systematic review provides a timely update on the type 
and severity of complications of abortions where access to 
abortion is limited. Based on data from 70 studies from 
28 countries where access to abortion is limited, we esti-
mate that at least 9% of abortion-related hospital admis-
sions have near miss complications and approximately 
1.5% ends in a death. The case fatality was lower than 
that reported by Adler and colleagues, most likely due 
to differences in the way the study estimates were pooled 
in the two different reviews.6 Consistent with the clinical 
literature, bleeding and infection were common compli-
cations among abortion-related hospitalisations, and we 
note high levels of anaemia which is likely to be linked 
to haemorrhage. Overall, there was higher prevalence 
of haemorrhage than sepsis with 9% of abortion-related 
hospital admissions experiencing near-miss cases due to 
haemorrhage, while 57% had non-severe or unspecified 
haemorrhage. Near-miss cases due to sepsis accounted 
for 3% of abortion-related complications, while non-se-
vere or unspecified sepsis accounted for 18% of these 
admissions.
Our comparison of pooled estimates from studies with 
a median year of data collection between 1990 and 1995 
and those with a median year of 2009–2013 suggest that 
the percentage of abortion-related hospital admissions 
with extremely severe complications has increased, while 
case fatality has stayed relatively consistent. Even after 
accounting for some of the methodological differences 
between the studies using meta-regression, we still found 
evidence for an increase in the percentage of abortion-re-
lated hospitals admissions with near-miss complications. 
A nationally representative study conducted in Ethiopia, 
published since our search was conducted, also docu-
mented an increase in the number of women seeking 
post abortion care with severe abortion morbidity from 
2008 to 2014 of 7%–11%.30 We also have some surprising 
complication-specific results with, for example, the 
pooled percentage of abortion-related hospital admis-
sions with near miss due to sepsis increasing from 0.4% in 
studies conducted in the early period, compared with 9% 
in the most recent studies. Pooled estimates of near miss 
due to haemorrhage also showed a dramatic increase 
over time from 3% to 27%. These results do need to be 
interpreted with caution, as some pooled estimates are 
made based only on a few studies.
It is likely that improvements in measurement and 
recording over time have contributed, at least in part, to 
the patterns we observe. As, for example, researchers and 
hospital staff have become more aware of the near miss 
definition, cases of near miss due to abortion are more 
likely to be recorded and therefore counted in our esti-
mates. It is, however, also plausible that there has been an 
increase in the percentage of abortion-related complica-
tions treated in health facilities that are near miss. There 
may have been an absolute decrease in the number of 
women with less severe abortion-related complications 
coming to the hospital because they are seeking care in 
lower-level facilities. This would mean that the severe 
complications account for a larger percentage of all abor-
tion-related hospital admissions. Alternatively, decreasing 
stigma or fear of being prosecuted in some areas and/or 
increasing availability of postabortion care in facilities, 
may mean more women who have severe abortion-re-
lated complications are coming to hospital for treatment. 
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If this is the case, we would expect that abortion-related 
mortality is decreasing in the community. A final possible 
explanation is that as fertility declines across many 
settings, women who wish to reduce their fertility but 
have unmet need for contraception either due to finan-
cial barriers or due to concerns about side effects, instead 
seek out unsafe abortions, which may in turn increase the 
severity of the abortion complications observed within 
facilities. This final pathway, however, is not well docu-
mented in the literature.
Very high heterogeneity between the study estimates, 
across almost every pooled estimate we calculated, means 
our results must be interpreted with caution. This is not 
surprising given the observational nature of the data, and 
the differences between the studies with respect to the 
type of abortions included, the study design and the vari-
ations in the definitions of some of the complications. 
Meta-regression analysis of near miss and case fatality 
estimates enabled us to explore the influence of method-
ological differences between studies. It is clear that some 
of the difference between studies are driven by study level 
factors, particularly the definition of hospital-related 
abortion admissions and, for near miss, the way in which 
we calculated an estimate of near miss cases for each 
study, which is in turn related to the quality of reporting. 
We see that studies which only look at induced abortion 
have higher case fatality than studies also including spon-
taneous abortions. Complications are more likely after 
an induced than a spontaneous abortion, but the vastly 
increased case fatality rate in these studies may also be 
driven by a hospital-related abortion admission being 
more likely to be classified as an induced abortion from 
the severity of the complication.
Another important limitation was in the study quality, 
and as with all reviews, the summary estimates from this 
systematic review are only as good as the data on which 
they are based. The risk of bias assessment indicated that 
most studies were at high risk of bias in at least one of the 
domains. We have particular concerns over our estimates 
of near miss complications due to the lack of studies 
explicitly defining complications in line with well estab-
lish near miss criteria. Further, for many studies, we could 
only estimate a minimum number of cases that were near 
miss by selecting the single largest complication that 
fitted the near miss definition. This will undoubtedly 
be an underestimate of the true number of women who 
near miss complications in these studies.
As access to misoprostol increases, and more abortions 
are self-induced with this method, it should lead to rarer 
abortion-related mortality at the population level. Under-
standing women’s care needs remains important and 
measuring morbidity as a heath outcome measure will 
continue play a crucial part in this.31 The availability of a 
standardised definition and tools for measuring maternal 
near miss by WHO in 2009 was a welcome development 
to standardise the abortion near miss data collected from 
different contexts.5 31 However, these criteria and tools 
may need to be refined for abortion and for low-income 
and middle-income settings.32 33 Future facility-based 
research studies should use standard definitions such as 
the WHO near miss consistently and/or clearly define the 
clinical criteria applied in their studies, ideally collecting 
this data prospectively and stratifying results by gesta-
tional age, method of inducing abortion and the abor-
tion provider information. There should also be a push 
to collect data from population-representative samples of 
facilities to understand admission patterns at the popula-
tion level and generate trends in safety over time. By only 
focussing on hospital admissions, we have not quantified 
the full spectrum of risk associated with unsafe abortion. 
As self-use of medical abortion continues to expand, it 
will be is necessary to increase and improve represen-
tative community-level data collection on abortion care 
seeking and outcomes.
In spite of the challenges on how near miss morbidity 
has been defined and measured in the included studies, 
our results suggest that a substantial percentage of 
abortion-related hospital admissions have potentially 
life-threatening complications, highlighting the impor-
tance of providing high-quality postabortion care. Ulti-
mately, health outcomes are essential indicators to assert 
progress in healthcare services. Any reproductive health 
programme that aims at the local level to reduce maternal 
deaths from unwanted or unplanned pregnancies benefits 
from good measurement of health outcomes, including 
severe morbidity. Given the hidden nature of abortion 
and the stigma associated with it, health outcomes such 
as near miss that can be measured meaningfully in health 
facilities should be particularly useful for evaluation and 
monitoring.
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